cyclopentane has been researched along with muramidase in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, M; Omura, F; Otsu, M; Tashiro, Y; Yoshimori, T | 1 |
| Adorini, L; Fuchs, S; Hämmerling, GJ; Heuser, A; Momburg, F; Moreno, J; Nadimi, F | 1 |
| Adorini, L; Appella, E; Fuchs, S; Ullrich, SJ | 1 |
| Füllekrug, J; Mieskes, G; Nguyen Van, P; Schäfer, U; Söling, HD; Sönnichsen, B | 1 |
| Giordano, C; Lucente, G; Paradisi, MP; Sansone, A; Spisani, S; Torino, D | 1 |
| Al-Hussain, SA; Edrees, MM; Farghaly, TA; Muhammad, ZA; Shabaan, SN; Zaki, MEA | 1 |
6 other study(ies) available for cyclopentane and muramidase
| Article | Year |
|---|---|
Non-lysosomal degradation of misfolded human lysozymes with and without an asparagine-linked glycosylation site.
Topics: Animals; Asparagine; Base Sequence; Binding Sites; Brefeldin A; Carbohydrate Conformation; Cyclopentanes; Disulfides; Fluorescent Antibody Technique; Gene Expression; Glycosylation; Humans; L Cells; Mice; Molecular Sequence Data; Muramidase; Mutagenesis, Site-Directed; Protein Folding; Protein Processing, Post-Translational; Transfection; Vero Cells | 1992 |
Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
Topics: Animals; Antigen-Presenting Cells; Antigens, Differentiation, B-Lymphocyte; Brefeldin A; Cyclopentanes; Egg Proteins; Histocompatibility Antigens Class II; Muramidase; Rats; Ribonuclease, Pancreatic; Transfection | 1991 |
Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Topics: Animals; Antigen-Presenting Cells; Antigens; Brefeldin A; Cell Compartmentation; Cell Line; Cyclopentanes; Histocompatibility Antigens Class II; In Vitro Techniques; Mice; Muramidase; Ovalbumin; Peptides; Solubility; T-Lymphocytes | 1990 |
Characterization of brefeldin A induced vesicular structures containing cycling proteins of the intermediate compartment/cis-Golgi network.
Topics: Animals; Brefeldin A; Cell Compartmentation; Chlorocebus aethiops; Cyclopentanes; Endoplasmic Reticulum; Galactosyltransferases; Golgi Apparatus; Mannose-Binding Lectins; Mannosidases; Membrane Proteins; Muramidase; Receptors, Peptide; Subcellular Fractions; Vero Cells | 1997 |
Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
Topics: Allyl Compounds; Allylglycine; Carboxylic Acids; Chemotactic Factors; Cyclopentanes; Glycine; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protein Folding; Superoxides | 2008 |
Dry Grinding Synthesis and Docking Study of Cyclopentanone-Sulfur Containing Compounds with Anti-Proliferative Activity for HepG-2 and A-549 Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Drug Screening Assays, Antitumor; Humans; Macrophage Migration-Inhibitory Factors; Molecular Docking Simulation; Molecular Structure; Muramidase; Structure-Activity Relationship; Sulfur; Sulfur Compounds; Thiazoles | 2022 |